SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Themis Medicare Ltd

BSE: 530199 NSE: THEMISMED ISIN: INE083B01024
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Themis Medicare Ltd belong to?
Themis Medicare Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Themis Medicare Ltd a good quality company?
Themis Medicare Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is Themis Medicare Ltd undervalued or overvalued?
Themis Medicare Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Themis Medicare Ltd a good buy now?
Themis Medicare Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Themis Medicare Ltd?
Themis Medicare Ltd revenue growth is 6.2% for FY-2025 , which is below its 5 year CAGR of 15% , indicating slower growth.
Q.2 Gross Profit margin of Themis Medicare Ltd?
Themis Medicare Ltd Gross profit margin which is the profit after deduction of direct costs, is 10.8% for FY-2025 , which is below its 5 year median of 17.7% , indicating decreasing margins.
Q.3 Operating Profit Margin of Themis Medicare Ltd?
Themis Medicare Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 12.11% for FY-2025 , which is below its 5 year median of 19.04% indicating decreasing margins.
Q.4 Net Profit Margin of Themis Medicare Ltd?
Themis Medicare Ltd Net Profit Margin is 5.9% for FY-2025 , is below with its 5 year median of 11.54%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 10.8 17.7
Operating Profit Margin 12.11 19.04
Net Profit Margin 5.9 11.54
Q.5 Return on Asset of Themis Medicare Ltd?
Themis Medicare Ltd Return on Asset is 4.71%, which is below its 5 year historical median of 8.07%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Themis Medicare Ltd?
Themis Medicare Ltd Return on equity is 7.7% for FY-2025 , which is below its historical median of 15.47%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Themis Medicare Ltd?
Themis Medicare Ltd Return on capital employed is 10.95% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Themis Medicare Ltd?
Themis Medicare Ltd Cash conversion cycle is 174 days, above its historical median of 166 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.8 0.8
ROE 7.7 15.47
ROCE 10.95 16.98
Cash Conversion Cycle 174 days 166 days
Q.9 Debt to Equity ratio of Themis Medicare Ltd?
Themis Medicare Ltd Debt-to-Equity ratio is 0.26 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Themis Medicare Ltd?
Themis Medicare Ltd Debt to cash flow from operations is 2.39 , which is at a moderate level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Themis Medicare Ltd?
Promoters hold 67.11% of the Themis Medicare Ltd, with 2.43% of their stake pledged, indicating low pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Themis Medicare Ltd vs industry peers?
Themis Medicare Ltd revenue CAGR is 15.00% , compared to the industry median CAGR of 5.51% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 405.5 138.8
Gross Profit 43.9 16.2
Operating Profit 49 16
Net Profit 24 5.3
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.8 0.79
ROE 7.7 9.17
ROCE 10.95 11.78
Cash Conversion Cycle (days) 173.82 76

Valuation & price assessment

Q.1 Stock return of Themis Medicare Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 8.8% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 8.8% 20.8% -11.7% -30.6%
Q.3 Valuation ratios of Themis Medicare Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings - 26.56 40.28
Price to Book 2.79 4.23 2.77
Price to Sales 2.48 3.17 2.65
EV to EBITDA -484.75 16.85 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Sai Life Sciences
8. Astrazeneca Pharma I
9. Piramal Pharma
10. Acutaas Chemicals
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×